Surgery after neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer

Surgery is the standard of care for patients with operable non-small cell lung cancer (NSCLC). However, as a single modality, surgery for early stage or locally advanced NSCLC remains associated with high rates of local and distant recurrence. The addition of neoadjuvant or adjuvant chemotherapy has...

Descripción completa

Detalles Bibliográficos
Autores principales: Huynh, Caroline, Walsh, Logan A., Spicer, Jonathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Articles on Multimodal Management of Locally Advanced N2 Non-small Cell Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867741/
https://www.ncbi.nlm.nih.gov/pubmed/33569337
http://dx.doi.org/10.21037/tlcr-20-509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867741/
https://www.ncbi.nlm.nih.gov/pubmed/33569337
http://dx.doi.org/10.21037/tlcr-20-509

Ejemplares similares